📚 Lecture Overview
This lecture covers the clinical classification, pathogenesis, and comprehensive assessment of Diabetes Mellitus. It is essential for medical students to master how to diagnose different types of diabetes, recognize their underlying mechanisms, and screen for critical chronic complications.
🎯 Key Concepts & Definitions
- Hyperglycemia: Elevated blood glucose levels from a clinical point of view.
- Type 1 Diabetes (T1D): Auto-immune destruction of pancreatic islet beta cells leading to absolute insulin deficiency, often presenting acutely with diabetic ketoacidosis.
- Type 2 Diabetes (T2D): Characterized primarily by insulin resistance with a variable degree of beta cell dysfunction, heavily linked to genetics and visceral obesity.
- Secondary Diabetes: Hyperglycemia caused by specific external factors such as endocrine diseases, drugs (corticosteroids, antipsychotics), or exocrine pancreatic disease.
- Gestational Diabetes (GDM): Diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation.
- C-Peptide: A marker of endogenous insulin levels; low or absent in T1D and normal or high in T2D.
- UACR (Urinary Albumin-to-Creatinine Ratio): A primary screening test used to detect diabetic nephropathy (abnormal if >30 mg/g).
📖 Main Content
1. Clinical Assessment Pillars
The complete clinical evaluation of a diabetes patient addresses four core questions:
- Are they diabetic or not?
- What is the type of diabetes?
- Are there any complications?
- Are there any co-morbidities?
2. Type 1 vs Type 2 Diabetes Mellitus
- Type 1 Diabetes:
- Most common in children and young adults (<20 years).
- Onset is typically acute with polyuria, polydipsia, polyphagia, and weight loss.
- Frequently presents with Diabetic Ketoacidosis (DKA).
- Diagnosis is clinical, supported by labs like low C-peptide and positive auto-antibodies (GAD65, IAA, ICA).
- Type 2 Diabetes:
- Predominantly in adults >30 years (and increasingly in overweight youth).
- Main etiological factor is insulin resistance combined with beta-cell dysfunction.
- Strongly linked to visceral obesity (omental and mesenteric fat accumulation); subcutaneous fat is not involved in insulin resistance.
- Often asymptomatic and found accidentally or upon presentation with chronic complications.
3. Secondary and Gestational Diabetes
- Secondary Diabetes:
- Endocrine causes: excessive growth hormone, glucocorticoids, or thyroid hormones ("diabetogenic" hormones).
- Drug-induced: corticosteroids increase insulin resistance, atypical antipsychotics cause weight gain and resistance, and calcineurin inhibitors (cyclosporine, tacrolimus) impair insulin secretion.
- Pancreatic causes: chronic pancreatitis or pancreatectomy requiring insulin replacement.
- Gestational Diabetes (GDM):
- Physiological insulin resistance occurs naturally in the 2nd and 3rd trimesters. GDM occurs when pancreatic beta-cell function cannot compensate for this resistance.
- Safe insulin options in pregnancy include NPH, Regular, Lispro, Aspart, Detemir, and recently approved Degludec.
4. Screening for Chronic Complications
- Diabetic Nephropathy:
- Test UACR annually (start at diagnosis for T2D; 5 years post-diagnosis for T1D).
- Measure serum creatinine annually to estimate eGFR and stage chronic kidney disease.
- Diabetic Retinopathy:
- Require dilated eye exams by an ophthalmologist annually (start at diagnosis for T2D; 5 years post-diagnosis for T1D).
- Diabetic Foot:
- Comprehensive foot examination annually using tuning forks and monofilaments to assess neurological status.
📊 Visual Learning
💡 Important Points to Remember
- Visceral obesity, not subcutaneous fat, drives insulin resistance in Type 2 Diabetes.
- C-peptide is low or absent in Type 1 Diabetes and normal to high in Type 2 Diabetes.
- UACR screening starts immediately at diagnosis for Type 2 Diabetes, but 5 years after diagnosis for Type 1 Diabetes.
- Retinopathy and Foot exams follow the same screening timeline: immediately at diagnosis for T2D, and 5 years after diagnosis for T1D.
- Corticosteroids worsen hyperglycemia primarily by increasing insulin resistance.
- Safe insulins in pregnancy include NPH, Regular, Lispro, Aspart, Detemir, and Degludec.
- Hypertension in diabetes is diagnosed when confirmed with multiple readings exceeding 130/80 mmHg.
- Common confusion: Do not confuse subcutaneous fat with visceral fat regarding insulin resistance risks.
⚠️ Common Exam Questions
Examiners frequently test the differentiation timelines between Type 1 and Type 2 diabetes screening protocols. A classic MCQ trap is asking when to start nephropathy or retinopathy screening for a T1D patient versus a T2D patient, reversing the "at diagnosis" vs "5 years after diagnosis" rules. Another common trick is listing unsafe medications during pregnancy or misidentifying which fat depot contributes to metabolic syndrome and insulin resistance.
📝 Quick Review Checklist
I can explain the primary pathogenesis of Type 1 vs Type 2 Diabetes
I understand the physiological reasons behind Gestational Diabetes in later trimesters
I can define the screening timelines for diabetic nephropathy, retinopathy, and neuropathy
I know which drugs and hormones cause secondary diabetes
I can list the safe insulin therapies approved for use during pregnancy